Suppr超能文献

Spiegelmer NOX-A50 靶向细胞内高迁移率族蛋白 A1(HMGA1)的聚乙二烯亚胺多聚物可减少体内肿瘤生长。

Polyetheylenimine-polyplexes of Spiegelmer NOX-A50 directed against intracellular high mobility group protein A1 (HMGA1) reduce tumor growth in vivo.

机构信息

NOXXON Pharma AG, Max-Dohrn-Strasse 8-10, D-10589 Berlin, Germany.

出版信息

J Biol Chem. 2010 Dec 17;285(51):40012-8. doi: 10.1074/jbc.M110.178533. Epub 2010 Oct 20.

Abstract

High mobility group A1 (HMGA1) proteins belong to a group of architectural transcription factors that are overexpressed in a range of human malignancies, including pancreatic adenocarcinoma. They promote anchorage-independent growth and epithelial-mesenchymal transition and are therefore suggested as potential therapeutic targets. Employing in vitro selection techniques against a chosen fragment of HMGA1, we have generated biostable l-RNA oligonucleotides, so-called Spiegelmers, that specifically bind HMGA1b with low nanomolar affinity. We demonstrate that the best binding Spiegelmers, NOX-A50 and NOX-f33, compete HMGA1b from binding to its natural binding partner, AT-rich double-stranded DNA. We describe a formulation method based on polyplex formation with branched polyethylenimine for efficient delivery of polyethylene glycol-modified Spiegelmers and show improved tissue distribution and persistence in mice. In a xenograft mouse study using the pancreatic cancer cell line PSN-1, subcutaneous administration of 2 mg/kg per day NOX-A50 formulated in polyplexes showed an enhanced delivery of NOX-A50 to the tumor and a significant reduction of tumor volume. Our results demonstrate that intracellular targets can be successfully addressed with a Spiegelmer using polyethylenimine-based delivery and underline the importance of HMGA1 as a therapeutic target in pancreatic cancer.

摘要

高迁移率族蛋白 A1(HMGA1)蛋白属于一类结构转录因子,在多种人类恶性肿瘤中过度表达,包括胰腺腺癌。它们促进锚定非依赖性生长和上皮-间充质转化,因此被认为是潜在的治疗靶点。我们采用针对 HMGA1 选定片段的体外选择技术,生成了生物稳定的 l-RNA 寡核苷酸,即所谓的 Spiegelmers,它们以低纳摩尔亲和力特异性结合 HMGA1b。我们证明,最佳结合 Spiegelmers,NOX-A50 和 NOX-f33,可竞争 HMGA1b 与其天然结合伴侣富含 AT 的双链 DNA 的结合。我们描述了一种基于多聚体形成的制剂方法,使用支化聚乙烯亚胺可有效递送至经聚乙二醇修饰的 Spiegelmers,并显示出在小鼠中改善的组织分布和持久性。在使用胰腺癌细胞系 PSN-1 的异种移植小鼠研究中,每天以 2mg/kg 的剂量皮下给予多聚体包封的 NOX-A50,可增强 NOX-A50 向肿瘤的递送,并显著减少肿瘤体积。我们的结果表明,使用基于聚乙烯亚胺的递送可以成功地用 Spiegelmer 靶向细胞内靶标,并强调 HMGA1 作为胰腺癌治疗靶点的重要性。

相似文献

2
HMGA-targeted phosphorothioate DNA aptamers increase sensitivity to gemcitabine chemotherapy in human pancreatic cancer cell lines.
Cancer Lett. 2012 Feb 1;315(1):18-27. doi: 10.1016/j.canlet.2011.10.005. Epub 2011 Oct 10.
4
Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells.
Br J Cancer. 2007 Mar 26;96(6):993-1000. doi: 10.1038/sj.bjc.6603654. Epub 2007 Mar 6.
5
HMGA and Cancer: A Review on Patent Literatures.
Recent Pat Anticancer Drug Discov. 2019;14(3):258-267. doi: 10.2174/1574892814666190919152001.
8
Extracellular HMGA1 Promotes Tumor Invasion and Metastasis in Triple-Negative Breast Cancer.
Clin Cancer Res. 2018 Dec 15;24(24):6367-6382. doi: 10.1158/1078-0432.CCR-18-0517. Epub 2018 Aug 22.
10
Physicochemical stability of NOX-E36, a 40mer L-RNA (Spiegelmer) for therapeutic applications.
Nucleic Acids Symp Ser (Oxf). 2008(52):61-2. doi: 10.1093/nass/nrn031.

引用本文的文献

1
The clinical potential of l-oligonucleotides: challenges and opportunities.
Chem Sci. 2024 Oct 21;15(44):18239-58. doi: 10.1039/d4sc05157b.
2
DNA-Based Nanomaterials as Drug Delivery Platforms for Increasing the Effect of Drugs in Tumors.
Cancers (Basel). 2023 Apr 5;15(7):2151. doi: 10.3390/cancers15072151.
3
High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential.
Int J Biol Sci. 2022 Jul 4;18(11):4414-4431. doi: 10.7150/ijbs.72952. eCollection 2022.
4
Circular and linear: a tale of aptamer selection for the activation of SIRT1 to induce death in cancer cells.
RSC Adv. 2020 Dec 21;10(73):45008-45018. doi: 10.1039/d0ra07857c. eCollection 2020 Dec 17.
5
Advances in Therapeutic -Nucleosides and -Nucleic Acids with Unusual Handedness.
Genes (Basel). 2021 Dec 24;13(1):46. doi: 10.3390/genes13010046.
6
Aptamers: A Review of Their Chemical Properties and Modifications for Therapeutic Application.
Molecules. 2019 Nov 21;24(23):4229. doi: 10.3390/molecules24234229.
7
HMGA1a Induces Alternative Splicing of the α Gene by Trapping U1 snRNP to an Upstream Pseudo-5' Splice Site.
Front Mol Biosci. 2018 Jun 8;5:52. doi: 10.3389/fmolb.2018.00052. eCollection 2018.
8
Mandatory role of HMGA1 in human airway epithelial normal differentiation and post-injury regeneration.
Oncotarget. 2018 Feb 16;9(18):14324-14337. doi: 10.18632/oncotarget.24511. eCollection 2018 Mar 6.
9
Aptamers in Therapeutics.
J Clin Diagn Res. 2016 Jun;10(6):BE01-6. doi: 10.7860/JCDR/2016/18712.7922. Epub 2016 Jun 1.
10
An L-RNA Aptamer that Binds and Inhibits RNase.
Chem Biol. 2015 Nov 19;22(11):1437-1441. doi: 10.1016/j.chembiol.2015.09.017.

本文引用的文献

1
HMGA and cancer.
Biochim Biophys Acta. 2010 Jan-Feb;1799(1-2):48-54. doi: 10.1016/j.bbagrm.2009.11.007.
4
Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice.
J Am Soc Nephrol. 2007 Aug;18(8):2350-8. doi: 10.1681/ASN.2006121348. Epub 2007 Jul 11.
5
An L-RNA-based aquaretic agent that inhibits vasopressin in vivo.
Proc Natl Acad Sci U S A. 2006 Mar 28;103(13):5173-8. doi: 10.1073/pnas.0509663103. Epub 2006 Mar 17.
6
Increased expression of high mobility group A proteins in lung cancer.
J Pathol. 2006 Jun;209(2):206-12. doi: 10.1002/path.1960.
9
Design and development of polymers for gene delivery.
Nat Rev Drug Discov. 2005 Jul;4(7):581-93. doi: 10.1038/nrd1775.
10
Polyethylenimine-based non-viral gene delivery systems.
Eur J Pharm Biopharm. 2005 Jul;60(2):247-66. doi: 10.1016/j.ejpb.2004.11.011.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验